SAGE and related approaches for cancer target identification

被引:10
作者
Porter, D
Yao, J
Polyak, K [1 ]
机构
[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
D O I
10.1016/S1359-6446(05)03694-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Comprehensive genetic, epigenetic and transcriptional analyses of normal and cancerous tissues and cells have yielded many candidate diagnostic, predictive, and prognostic markers and therapeutic targets in human cancer. This article provides a brief overview of SAGE and SAGE-like techniques, highlighting their utility and advantages relative to other genomic technologies for the discovery of drug targets. We also summarize the results of recent comprehensive profiling studies that utilize these methods to provide insights into mechanisms of tumor initiation and progression, to improve our molecular understanding of the tumor microenvironment and to reveal new targets and avenues for therapeutic interventions.
引用
收藏
页码:110 / 118
页数:9
相关论文
共 62 条
[41]   High-resolution genome-wide mapping of histone modifications [J].
Roh, TY ;
Ngau, WC ;
Cui, KR ;
Landsman, D ;
Zhao, KJ .
NATURE BIOTECHNOLOGY, 2004, 22 (08) :1013-1016
[42]  
ROH TY, 2005, GENE DEV, V19, P452
[43]   A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors [J].
Rubin, JB ;
Kung, AL ;
Klein, RS ;
Chan, JA ;
Sun, YP ;
Schmidt, K ;
Kieran, MW ;
Luster, AD ;
Segal, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13513-13518
[44]   Using the transcriptome to annotate the genome [J].
Saha, S ;
Sparks, AB ;
Rago, C ;
Akmaev, V ;
Wang, CJ ;
Vogelstein, B ;
Kinzler, KW ;
Velculescu, VE .
NATURE BIOTECHNOLOGY, 2002, 20 (05) :508-512
[45]   Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells [J].
Sherman-Baust, CA ;
Weeraratna, AT ;
Rangel, LBA ;
Pizer, ES ;
Cho, KR ;
Schwartz, DR ;
Shock, T ;
Morin, PJ .
CANCER CELL, 2003, 3 (04) :377-386
[46]   Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage [J].
Shiraki, T ;
Kondo, S ;
Katayama, S ;
Waki, K ;
Kasukawa, T ;
Kawaji, H ;
Kodzius, R ;
Watahiki, A ;
Nakamura, M ;
Arakawa, T ;
Fukuda, S ;
Sasaki, D ;
Podhajska, A ;
Harbers, M ;
Kawai, J ;
Carninci, P ;
Hayashizaki, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15776-15781
[47]   Gene expression correlates of clinical prostate cancer behavior [J].
Singh, D ;
Febbo, PG ;
Ross, K ;
Jackson, DG ;
Manola, J ;
Ladd, C ;
Tamayo, P ;
Renshaw, AA ;
D'Amico, AV ;
Richie, JP ;
Lander, ES ;
Loda, M ;
Kantoff, PW ;
Golub, TR ;
Sellers, WR .
CANCER CELL, 2002, 1 (02) :203-209
[48]   CXCR4 regulates growth of both primary and metastatic breast cancer [J].
Smith, MCP ;
Luker, KE ;
Garbow, JR ;
Prior, JL ;
Jackson, E ;
Piwnica-Worms, D ;
Luker, GD .
CANCER RESEARCH, 2004, 64 (23) :8604-8612
[49]   Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J].
Sorlie, T ;
Perou, CM ;
Tibshirani, R ;
Aas, T ;
Geisler, S ;
Johnsen, H ;
Hastie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Thorsen, T ;
Quist, H ;
Matese, JC ;
Brown, PO ;
Botstein, D ;
Lonning, PE ;
Borresen-Dale, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10869-10874
[50]  
St Croix B, 2000, SCIENCE, V289, P1197